February 2024 Br J Cardiol 2024;31:28–30 doi:10.5837/bjc.2024.007
Peter S Giannaris, Viren S Sehgal, Branden Tejada, Kenzy H Ismail, Roshan Pandey, Eamon Vega, Kathryn Varghese, Ahmed K Awad, Adham Ahmed, Irbaz Hameed
Introduction Individuals with bicuspid aortic valves (BAV) are at an elevated risk for developing aortic stenosis.1 Currently, transcatheter aortic valve replacement (TAVR) has emerged as a less invasive alternative to surgical aortic valve replacement (SAVR), demonstrating non-inferior to superior outcomes across patients of various risk levels.2 Less clear, however, are the outcomes of these modalities in BAV patients, as this population has been relatively underrepresented in many large studies. Due to the growing use of TAVR, we performed an updated pairwise meta-analysis on TAVR in comparison to SAVR in patients with BAV. Method This stu
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits